A novel chiral stationary phase HPLC-MS/MS method to discriminate between enzymatic oxidation and auto-oxidation of phosphatidylcholine
- 380 Downloads
To elucidate the role of enzymatic lipid peroxidation in disease pathogenesis and in food deterioration, we recently achieved stereoselective analysis of phosphatidylcholine hydroperoxide (PCOOH) possessing 13S-hydroperoxy-9Z,11E-octadecadienoic acid (13(S)-9Z,11E-HPODE) using HPLC-MS/MS with a CHIRALPAK OP (+) column. Because enzymatic oxidation progresses concurrently with auto-oxidation, we need to distinguish them further. Here, we attempted such an analysis. First, we used lipoxygenase, linoleic acid, and lysophosphatidylcholine (LPC) to synthesize the enzymatic oxidation product 13(S)-9Z,11E-HPODE PC, and the auto-oxidation products 13(RS)-9Z,11E-HPODE PC and 13(RS)-9E,11E-HPODE PC, which were used as standards to test the ability of various columns to separate the enzymatic oxidation product from auto-oxidation products. Separation was achieved by connecting in series two columns with different properties: CHIRALPAK OP (+) and CHIRALPAK IB-3. The CHIRALPAK OP (+) column separated 13(R)-9Z,11E-HPODE PC and 13(S)-9Z,11E-HPODE PC, whereas CHIRALPAK IB-3 enabled separation of 13(S)-9Z,11E-HPODE PC and 13(RS)-9E,11E-HPODE PC. The results for the analysis of both enzymatically oxidized and auto-oxidized lecithin (an important phospholipid mixture in vivo and in food) indicate that our method would be useful for distinguishing enzymatic oxidation and auto-oxidation reactions. Such information will be invaluable for elucidating the involvement of PCOOH in disease pathogenesis and in food deterioration.
KeywordsChiral stationary phase Chiral column Phosphatidylcholine hydroperoxide Lipid oxidation LC-MS/MS
- 16:0 LPC
- 16:0/18:2 PC
chiral stationary phase
nuclear magnetic resonance
selected reaction monitoring.
This work was supported by Grant-in-Aid for Scientific Research (B) Grant Number 15H04497.
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest associated with this work.
- 2.Kinoshita M, Oikawa S, Hayasaka K, Sekikawa A, Nagashima T, Toyota T, et al. Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia. Clin Chem. 2000;46:822–8.Google Scholar
- 7.Funk CD, Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med. 2001;11(3–4):116–24.Google Scholar
- 9.Ito J, Nakagawa K, Kato S, Hirokawa T, Kuwahara S, Nagai T, et al. Direct separation of the diastereomers of phosphatidylcholine hydroperoxide bearing 13-hydroperoxy-9Z,11E-octadecadienoic acid using chiral stationary phase high-performance liquid chromatography. J Chromatogr A. 2015;1386:53–61.CrossRefGoogle Scholar
- 10.Kato S, Nakagawa K, Suzuki Y, Asai A, Nagao M, Nagashima K, et al. Liquid chromatography-tandem mass spectrometry determination of human plasma 1-palmitoyl-2-hydroperoxyoctadecadienoyl-phosphatidylcholine isomers via promotion of sodium adduct formation. Anal Biochem. 2015;471:51–60.CrossRefGoogle Scholar
- 16.Younes AA, Mangelings D, Vander Heyden Y. Chiral separations in normal phase liquid chromatography: enantioselectivity of recently commercialized polysaccharide-based selectors. Part I: enantioselectivity under generic screening conditions. J Pharm Biomed Anal. 2011;55(3):414–23.CrossRefGoogle Scholar
- 19.Song Y, Jing W, Yang F, Shi Z, Yao M, Yan R, et al. Simultaneously enantiospecific determination of (+)-trans-khellactone, (+/−)-praeruptorin A, (+/-)-praeruptorin B, (+)-praeruptorin E, and their metabolites, (+/−)-cis-khellactone, in rat plasma using online solid phase extraction-chiral LC-MS/MS. J Pharm Biomed Anal. 2014;88:269–77.CrossRefGoogle Scholar